Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. (VVOS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
vvos · stock forecast · 5 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$2.50
Consensus
$2.13
+144.8% upside
Low
$1.75
Median: $2.125 · Last Close: $0.87
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$2.13
144.8% upside
High Target
$2.5
187.4%
Low Target
$1.75
101.1%
Current Price
$0.87
as of today
Based on analyst price targets, the VVOS stock price prediction for the next 12 months ranges from $1.75 to $2.5. The consensus VVOS price forecast of $2.13 implies 144.8% upside from the current price of $0.87.
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.91 | ↑ 5.00% |
1-day model range: $0.9–$0.93. Peak: $0.93 (+5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $0 | -50.0% |
| 2028 | $0 | -62.5% |
| 2029 | $0 | -67.2% |
| 2030 | $0 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · VVOS · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-04 | Ascendiant Capital | Maintains | Buy→Buy |
| 2026-04-22 | Ascendiant Capital | Maintains | Buy→Buy |
| 2026-04-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-03 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-09-09 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-04-15 | Ascendiant Capital | Maintains | Buy→Buy |
| 2024-11-20 | Ascendiant Capital | Maintains | Buy→Buy |
| 2024-11-19 | Alliance Global Partners | Maintains | Buy→Buy |
| 2024-08-20 | Ascendiant Capital | Maintains | Buy→Buy |
| 2023-01-17 | Ascendiant Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Vivos Therapeutics, Inc. (VVOS) stock. Of the recent 14 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover VVOS.
Analyst Recommendation Trends
VVOS analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$14M
↓ 32.3% YoY
Revenue Next Year
$15M
↑ 8.4% YoY
EPS This Year
$-5.91
EPS Next Year
$-2.02
↓ 65.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast VVOS EPS of $-5.91 for the current fiscal year, based on estimates from 1 analysts. The VVOS revenue forecast is $14M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The VVOS stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus VVOS price target is $2.13 (+144.8% upside), with an analyst consensus of Buy.
The VVOS short-term stock prediction for tomorrow is $0.91 (+5.00%). The VVOS stock price prediction for 2027 estimates an average of $0. The VVOS stock prediction for 2030 projects a range of $0–$0.
Vivos Therapeutics, Inc. trades on NASDAQ under the ticker VVOS. The VVOS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
VVOS forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month VVOS price target is $2.13, with a high forecast of $2.50 and a low of $1.75. The median price target is shown in the chart above when available. This implies +144.8% potential upside from the current price of $0.87.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.